Abraham Avigdor
- 専門分野: Hematologist
- 35年の経験
- 話します:English, Hebrew
- オンラインコンサルテーション:利用可能
- 勤務先: イスラエル, ラマト・ガン, シェバ医療センター
- Director of the Institute of Hematology; founder and president of the Israeli Lymphoma Working Group; author of 130+ scientific publications.
Dr. Abraham Avigdor is the Director of the Institute of Hematology at Sheba Medical Center. He is a global authority on lymphoma, CAR-T therapy, and complex blood cancers. Dr. Avigdor founded the Israeli Lymphoma Working Group. He helps lead a clinic ranked 7th worldwide by Newsweek in 2026.
- Authored over 130 scientific publications on hemato-oncology and cellular therapy.
- Pioneered the integration of CAR-T cell therapy for lymphoma and myeloma.
- Leads allogeneic and autologous bone marrow transplantation programs.
- Served as the Chairman of the Israeli Lymphoma Study Group.
Abraham Avigdorとのオンラインコンサルテーション
医師のサービス
- 化学療法
- 骨髄移植術
- CAR-T細胞療法
- 白血病化学療法
- 血漿交換術
- リンパ腫化学療法
- 半合致造血幹細胞移植術
- 同種骨髄移植術
- 非血縁者間同種骨髄移植術
- 治療的アフェレーシス
- カスケードプラズマろ過
- 血漿交換
- 選択的アフェレーシス
- 超音波検査
- CT検査
- 生検
- 腫瘍マーカー検査
- 免疫組織化学検査
- 骨髄生検
- オンライン相談(腫瘍専門医)
- MRI検査
調子はいかがですか?
資格
Prof. Abraham Avigdor directs the Institute of Hematology at Sheba Medical Center. He specializes in CAR–T therapy, lymphoma, and hemato-oncology. The specialist founded the Israeli Lymphoma Working Group and serves as its President. He uses his experience to lead programs in bone marrow transplantation and cellular therapies.
Specialization and Hematologic Focus
Dr. Avigdor treats blood cancers and immune system disorders. He specializes in lymphomas, including Hodgkin, Non-Hodgkin, and Burkitt’s lymphoma. The specialist also treats multiple myeloma, acute lymphoblastic leukemia, and various types of anemia. He integrates immunotherapy and targeted biological treatments into his practice.
His therapeutic approach integrates several techniques:
- CAR–T Cell Therapy for lymphoma and myeloma
- Bone Marrow Transplantation including autologous and allogeneic procedures
- Haploidentical Stem Cell Transplantation — a procedure using healthy blood-forming cells from a half-matched donor to replace diseased bone marrow
- Precision Diagnostics using PET/CT imaging as a prognostic tool
- Immunotherapy and biological targeted regimens
- Therapeutic Apheresis and plasma exchange protocols — methods that filter blood to remove harmful substances or abnormal cells
Academic and Clinical Leadership
Dr. Avigdor holds leadership positions at Sheba Medical Center and national bodies. He co-directs the Hematology and Bone Marrow Transplantation Division. Between 2011 and 2018, he served as Chairman of the Israeli Lymphoma Study Group. The specialist currently sits on the National Hematology Consultation Committee for the Health Basket.
Research and Professional Societies
The doctor contributes to medical science through clinical trials and partnerships. He has authored over 130 scientific publications. Dr. Avigdor collaborates with international organizations including:
- Lymphoma Study Association (LYSA), France
- European Mantle Cell Lymphoma Network (EMCL)
- International PET Study Groups in Lymphoma and Myeloma
Work Experience
- Director – Institute of Hematology, Sheba Medical Center
- Co-Director – Hematology and Bone Marrow Transplant Division, Sheba Medical Center
- Senior Lecturer – Tel Aviv University
- Former Chairman – Israeli Lymphoma Study Group (2011–2018)
- Founder and President – Israeli Lymphoma Working Group
Education and Training
- Medical Degree – Ben-Gurion University of the Negev
- Residency – Internal Medicine and Hematology, Sheba Medical Center
- Postdoctoral Fellowship – Stem Cell Biology, Weizmann Institute of Science
Awards and Recognition
- Knesset Prize – for excellence in medical studies
- Ministry of Health Award – for outstanding physician performance
- Sackler Prize – for research excellence at Tel Aviv University
こちらもご興味をお持ちいただけるかもしれません
支払い・特典
当社サービスへのお支払いはありません
クリニックで直接またはその公式銀行口座にお支払いいただきます。
一部のクリニックでは保証金が必要な場合があります。
分割払いオプションでお支払いを分散してください。
Bookimedにお友達を紹介して報酬を獲得してください。